{"nct_id":"NCT06834360","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2025-02-06","start_date_type":"ACTUAL","primary_completion_date":"2027-01-08","primary_completion_date_type":"ESTIMATED","completion_date":"2027-12-13","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["SNY"]}